Literature DB >> 21500267

T1 mapping of the gadolinium-enhanced myocardium: adjustment for factors affecting interpatient comparison.

Neville Gai1, Evrim B Turkbey, Saman Nazarian, Rob J van der Geest, Chia-Ying Liu, João A C Lima, David A Bluemke.   

Abstract

Quantitative T(1) mapping of delayed gadolinium-enhanced cardiac magnetic resonance imaging has shown promise in identifying diffuse myocardial fibrosis. Despite careful control of magnetic resonance imaging parameters, comparison of T(1) times between different patients may be problematic because of patient specific factors such as gadolinium dose, differing glomerular filtration rates, and patient specific delay times. In this work, a model driven approach to account for variations between patients to allow for comparison of T(1) data is provided. Kinetic model parameter values were derived from healthy volunteer time-contrast curves. Correction values for the factors described above were used to normalize T(1) values to a matched state. Examples of pre- and postcorrected values for a pool of normal subjects and in a patient cohort of type 1 diabetic patients shows tighter clustering and improved discrimination of disease state.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21500267      PMCID: PMC3092826          DOI: 10.1002/mrm.22716

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  32 in total

1.  Human myocardium: single-breath-hold MR T1 mapping with high spatial resolution--reproducibility study.

Authors:  Daniel R Messroghli; Sven Plein; David M Higgins; Kevin Walters; Timothy R Jones; John P Ridgway; Mohan U Sivananthan
Journal:  Radiology       Date:  2006-01-19       Impact factor: 11.105

2.  Quantitative assessment of glomerular filtration rate with MR gadolinium slope clearance measurements: a phase I trial.

Authors:  Andreas Boss; Petros Martirosian; Michael Gehrmann; Ferruh Artunc; Teut Risler; Niels Oesingmann; Claus D Claussen; Fritz Schick; Klaus Küper; Heinz-Peter Schlemmer
Journal:  Radiology       Date:  2007-01-05       Impact factor: 11.105

3.  Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart.

Authors:  Daniel R Messroghli; Andreas Greiser; Mirko Fröhlich; Rainer Dietz; Jeanette Schulz-Menger
Journal:  J Magn Reson Imaging       Date:  2007-10       Impact factor: 4.813

Review 4.  Magnetic resonance imaging in the evaluation of non-ischemic cardiomyopathies: current applications and future perspectives.

Authors:  Ilan Gottlieb; Robson Macedo; David A Bluemke; João A C Lima
Journal:  Heart Fail Rev       Date:  2006-12       Impact factor: 4.214

5.  Long-term effect of diabetes and its treatment on cognitive function.

Authors:  Alan M Jacobson; Gail Musen; Christopher M Ryan; Nancy Silvers; Patricia Cleary; Barbara Waberski; Amanda Burwood; Katie Weinger; Meg Bayless; William Dahms; Judith Harth
Journal:  N Engl J Med       Date:  2007-05-03       Impact factor: 91.245

6.  Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.

Authors:  Katherine C Wu; Robert G Weiss; David R Thiemann; Kakuya Kitagawa; André Schmidt; Darshan Dalal; Shenghan Lai; David A Bluemke; Gary Gerstenblith; Eduardo Marbán; Gordon F Tomaselli; João A C Lima
Journal:  J Am Coll Cardiol       Date:  2008-06-24       Impact factor: 24.094

Review 7.  Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies.

Authors:  Monda L Shehata; Evrim B Turkbey; Jens Vogel-Claussen; David A Bluemke
Journal:  Top Magn Reson Imaging       Date:  2008-02

8.  Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial.

Authors:  Raymond J Kim; Timothy S E Albert; James H Wible; Michael D Elliott; John C Allen; Jennifer C Lee; Michele Parker; Alicia Napoli; Robert M Judd
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

9.  Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.

Authors:  Leah Iles; Heinz Pfluger; Arintaya Phrommintikul; Joshi Cherayath; Pelin Aksit; Sandeep N Gupta; David M Kaye; Andrew J Taylor
Journal:  J Am Coll Cardiol       Date:  2008-11-04       Impact factor: 24.094

10.  Effect of Gd-DTPA-BMA on blood and myocardial T1 at 1.5T and 3T in humans.

Authors:  Puneet Sharma; Josh Socolow; Salil Patel; Roderic I Pettigrew; John N Oshinski
Journal:  J Magn Reson Imaging       Date:  2006-03       Impact factor: 4.813

View more
  61 in total

1.  Myocardial T1 mapping with MRI: comparison of look-locker and MOLLI sequences.

Authors:  Marcelo Souto Nacif; Evrim B Turkbey; Neville Gai; Saman Nazarian; Rob J van der Geest; Radwa A Noureldin; Christopher T Sibley; Martin Ugander; Songtao Liu; Andrew E Arai; João A C Lima; David A Bluemke
Journal:  J Magn Reson Imaging       Date:  2011-09-23       Impact factor: 4.813

2.  Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.

Authors:  Gaetano Nucifora; Daniele Muser; Pasquale Gianfagna; Giorgio Morocutti; Alessandro Proclemer
Journal:  Int J Cardiovasc Imaging       Date:  2015-07-26       Impact factor: 2.357

3.  Determination of location, size, and transmurality of chronic myocardial infarction without exogenous contrast media by using cardiac magnetic resonance imaging at 3 T.

Authors:  Avinash Kali; Ivan Cokic; Richard L Q Tang; Hsin-Jung Yang; Behzad Sharif; Eduardo Marbán; Debiao Li; Daniel S Berman; Rohan Dharmakumar
Journal:  Circ Cardiovasc Imaging       Date:  2014-03-28       Impact factor: 7.792

Review 4.  Tissue characterization of the myocardium: state of the art characterization by magnetic resonance and computed tomography imaging.

Authors:  Puskar Pattanayak; David A Bleumke
Journal:  Radiol Clin North Am       Date:  2014-12-18       Impact factor: 2.303

5.  Comprehensive evaluation of macroscopic and microscopic myocardial fibrosis by cardiac MR: intra-individual comparison of gadobutrol versus gadoterate meglumine.

Authors:  Amir Ali Rahsepar; Ahmadreza Ghasemiesfe; Kenichiro Suwa; Ryan S Dolan; Monda L Shehata; Monica J Korell; Nivedita K Naresh; Michael Markl; Jeremy D Collins; James C Carr
Journal:  Eur Radiol       Date:  2019-01-07       Impact factor: 5.315

6.  Cardiac MR imaging to probe tissue composition of the heart by using T1 mapping.

Authors:  Puskar Pattanayak; David A Bluemke
Journal:  Radiology       Date:  2014-05       Impact factor: 11.105

Review 7.  Cardiac MRI: a central prognostic tool in myocardial fibrosis.

Authors:  Bharath Ambale-Venkatesh; João A C Lima
Journal:  Nat Rev Cardiol       Date:  2014-10-28       Impact factor: 32.419

8.  Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy.

Authors:  Lu Fang; Andris H Ellims; Anna L Beale; Andrew J Taylor; Andrew Murphy; Anthony M Dart
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

9.  T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy.

Authors:  Christopher T Sibley; Radwa A Noureldin; Neville Gai; Marcelo Souto Nacif; Songtao Liu; Evrim B Turkbey; James O Mudd; Rob J van der Geest; João A C Lima; Marc K Halushka; David A Bluemke
Journal:  Radiology       Date:  2012-10-22       Impact factor: 11.105

Review 10.  Cardiac imaging techniques for physicians: late enhancement.

Authors:  Peter Kellman; Andrew E Arai
Journal:  J Magn Reson Imaging       Date:  2012-09       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.